News details

image
MarketWatch / 24 January, 2024

MedMen goes from height of $3B valuation to zero as stock draws cease-trade order

Once hailed as the first cannabis unicorn, MedMen’s fortunes have gone up in smoke.

Leave a Reply

Your email address will not be published. Required fields are marked